Pacira BioSciences (PCRX) Interest Coverage Ratio (2010 - 2026)
Pacira BioSciences (PCRX) posted Interest Coverage Ratio of 1.18 for Q2 2026, down 36.86% on a QoQ basis from 1.87 in Q1 2026, and down 34.92% year-over-year from 1.81 in Q2 2025.
Analysis
Pacira BioSciences (PCRX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Pacira BioSciences has reported Interest Coverage Ratio for 17 years, with the latest figure at 1.18 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio fell 34.92% year-over-year to 1.18 in Q2 2026; TTM through Jun 2026 was 1.28, a 122.92% increase from a year earlier, with the FY2025 full-year figure at 1.1, up 124.84% from the prior year.
- Interest Coverage Ratio was 1.18 for Q2 2026 at Pacira BioSciences, down from 1.87 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 10.32 in Q2 2023, with the low at 29.76 in Q3 2024.
- Average Interest Coverage Ratio over 5 years is 1.42, with a median of 1.84 recorded in 2025.
- The largest YoY upside for Interest Coverage Ratio was 1336.03% in 2024 against a maximum downside of 681.66% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 0.9 in 2022, then jumped by 1192.59% to 9.79 in 2023, then slumped by 46.08% to 5.28 in 2024, then plunged by 88.61% to 0.6 in 2025, then soared by 95.94% to 1.18 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.18 (Q2 2026), 1.87 (Q1 2026), and 0.6 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | - |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | -21.24 |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 114.07 |
| 10 | Pacira BioSciences | 1.01 Bn | 756.04 Mn | 148.24 Mn | 1.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 |
| Mar 31, 2026 | 1.87 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | 1.81 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 5.28 |
| Sep 30, 2024 | -29.76 |
| Jun 30, 2024 | 7.27 |
| Mar 31, 2024 | 3.98 |
| Dec 31, 2023 | 9.79 |
| Sep 30, 2023 | 5.12 |
| Jun 30, 2023 | 10.32 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.90 |
| Sep 30, 2022 | 2.16 |
| Jun 30, 2022 | 3.54 |
| Mar 31, 2022 | 1.70 |
| Dec 31, 2021 | 0.40 |
| Sep 30, 2021 | 4.29 |